Cellular basis of diabetic nephropathy: III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in Type 1 diabetic patients

Diabetologia

Volumn 47, Issue 10, 2004, Pages 1789-1794

  Huang, C ^a   Kim, Y ^a   Caramori, M L ^a   Fish, A J ^a   Rich, S S ^b   Miller, M E ^b   Russell, G B ^b   Mauer, M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular marker; Diabetic nephropathy; GLUT1; mRNA expression; Skin fibroblasts

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; MESSENGER RNA; RNA;

ADULT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETIC NEPHROPATHY; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; RNA ISOLATION; SKIN FIBROBLAST; STATISTICAL SIGNIFICANCE; TIME;

ADULT; BLOOD PRESSURE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FIBROBLASTS; GLOMERULAR FILTRATION RATE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; HYPERTENSION; MONOSACCHARIDE TRANSPORT PROTEINS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; SKIN;

EID: 11144252321     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-004-1533-1     Document Type: Article

References (35)

1. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
2. Krolewski AS, Fogarty DG, Warram JH (1998) Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? Diabetes Res Clin Pract 39 [Suppl]:S1-S14
3. Krolewski AS, Ng DP, Canani LH, Warram JH (2001) Genetics of diabetic nephropathy: how far are we from finding susceptibility genes? Adv Nephrol Necker Hosp 31:295-315
4. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320:1161-1165
5. Borch-Johnsen K, Norgaard K, Hommel E et al. (1992) Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722
6. Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39:940-945
7. Fioretto P, Steffes MW, Barbosa J, Rich SS, Miller ME, Mauer M (1999) Is diabetic nephropathy inherited? Studies of glomerular structure in type 1 diabetic sibling pairs. Diabetes 48:865-869
8. Trevisan R, Fioretto P, Barbosa J, Mauer M (1999) Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int 55:2383-2389
9. Lurbe A, Fioretto P, Mauer M, LaPointe MS, Batlle D (1996) Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter. Kidney Int 50:1684-1693
10. Trevisan R, Li LK, Messent J et al. (1992) Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246
11. Huang C, Kim Y, Caramori ML et al. (2002) Cellular basis of diabetic nephropahty: II. The TGF-b system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 51:3577-3581
12. Ceriello A, Morocutti A, Mercuri F et al. (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170-2177
13. Joost HG, Bell GI, Best JD et al. (2002) Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 282:E974-E976
14. Klip A, Tsakiridis T, Marette A, Ortiz PA (1994) Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J 8:43-53
15. Liu ZH, Guan TJ, Chen ZH, Li LS (1999) Glucose transporter (GLUT1) allele (XbaI-) associated with nephropathy in non-insulin-dependent diabetes mellitus. Kidney Int 55:1843-1848
16. Grzeszczak W, Moczulski DK, Zychma M, ZukowskaSzczechowska E, Trautsolt W, Szydlowska I (2001) Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes. Kidney Int 59:631-636
17. Gutierrez C, Vendrell J, Pastor R et al. (1998) GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population. Diabetes Res Clin Pract 41:113-120
18. Ng DP, Canani L, Araki S et al. (2002) Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes. Diabetes 51:2264-2269
19. Heilig CW, Brosius FC 3rd, Henry DN (1997) Glucose transporters of the glomerulus and the implications for diabetic nephropathy. Kidney Int Suppl 60:S91-S99
20. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P (1995) Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802-1814
21. Caramori ML, Kim Y, Huang C et al. (2002) Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51:506-513
22. Dangond F, Hwang D, Camelo S et al. (2004) Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16:229-239
23. Milliken G, Johnson, DE (1984) Analysis of messy data. Designed experiments, vol 1. Van Nostrand Reinhold, New York, p 33
24. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR (1985) The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794
25. Borch-Johnsen K, Nissen H, Salling N et al. (1987) The natural history of insulin-dependent diabetes in Denmark: 2. Long-term survival - who and why. Diabet Med 4:211-216
26. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155
27. Walker JD, Close CF, Jones SL et al. (1992) Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 41:741-748
28. Dalla Vestra M, Saller A, Bortoloso E, Mauer M, Fioretto P (2000) Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 26 [Suppl 4]:8-14
29. Chavers BM, Bilous RW, Ellis EN, Steffes MW, Mauer SM (1989) Glomerular lesions and urinary albumin excretion in type I diabetes without overt proteinuria. N Engl J Med 320:966-970
30. Caramori ML, Fioretto P, Mauer M (2000) The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes 49:1399-1408
31. Ng LL, Davies JE, Siczkowski M et al. (1994) Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 93:2750-2757
32. Iori E, Marescotti MC, Vedovato M et al. (2003) In situ protein kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy. Diabetologia 46:524-530
33. Caramori ML, Fioretto P, Mauer M (2003) Low glomemlar filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes 52:1036-1040
34. Heilig CW, Liu Y, England RL et al. (1997) D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy. Diabetes 46:1030-1039
35. Henry DN, Busik JV, Brosius FC 3rd, Heilig CW (1999) Glucose transporters control gene expression of aldose reductase, PKCalpha, and GLUT 1 in mesangial cells in vitro. Am J Physiol 277:F97-104